ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board
NORTHVALE, N.J., Sept. 18, 2014 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (OTCQB: ADMT) has appointed Gianluca DeNovi, Ph.D. to its corporate Advisory Board for business development.
Dr. DeNovi is an instructor at the Harvard Medical School and Visiting Professor at the University Campus Bio-Medico of Rome. He received his Masters degree in Electronics Engineering and his Ph.D. in Robotics and Control Systems from the University of Bologna. After spending a year as a visiting researcher at the Bio-Robotics Laboratory of Harvard School of Engineering and Applied Sciences, he completed his postdoctoral fellowship in medical simulation at the Department of Imaging of the Massachusetts General Hospital and Harvard Medical School in Boston.
Dr. DeNovi is a serial entrepreneur and has funded several successful companies in the med-tech and hi-tech fields. He has been a scientific consultant to many leading corporations and research institutions during his career.
Last year the PrimiDieci Society and the Italy-America Chamber of Commerce awarded Dr. DeNovi as one of the 10 most distinguished Italian Professionals in the USA under 40 years of age.
"We are very pleased to welcome Dr. DeNovi to our team as an advisor," stated Andre' DiMino, President of ADMT. "His business development knowledge and expertise, specifically in our technology fields, will be an invaluable asset to us in our growth plans."
Dr. DeNovi stated, "ADM Tronics is not only a very exciting company but I see in it tremendous opportunity, in terms of growth, being well situated with engineering, technological and regulatory capabilities in many areas of interest to me and my research. I look forward to a long and successful relationship with this company and for the many significant opportunities that can be pursued."
ADMT specializes in electronic medical device design, development and manufacturing for diagnostic and therapeutic medical technologies at its FDA-Registered Medical Device Manufacturing Facility. The Company is a one-stop source for complete design, engineering, regulatory and manufacturing services. ADMT has a number of proprietary medical devices. These proprietary devices, conceived, designed and produced in-house, include therapeutic and diagnostic medical technologies in fields as diverse as audiology, physical medicine, wound therapy, neurology and urology.
Dr. DeNovi's interest in computer-based surgery simulation started with exploration of cutting edge technologies for graphic rendering and development of a complete virtual reality framework optimized for surgery simulation. Since 2007, he has concentrated his research interests on physical simulation of soft tissues, creating new models and approaches optimized for haptic rendering. During his postdoctoral fellowship he focused on other crucial aspects of surgery simulation, such as real-time gesture analysis, task recognition and augmented reality. Here in the US he created several companies and founded and leads the consortium, Tritech Ventures, where together with partners, supports foreign companies interested in approaching the North American market.
About ADMT
ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three Business Segments: Proprietary Electronic Medical Devices; Eco-Friendly, Safe, Water-Based Formulations; and, Design, Engineering, Regulatory and Manufacturing Services. The Company's headquarters, laboratories, medical device and manufacturing operations are located in Northvale, NJ. ADMT's multi-disciplinary team of engineers, researchers and technologists utilize advanced technology infrastructure, such as 3-D solid prototyping, precision instrumentation and specialized software and peripherals for the research, development and commercialization of diversified technologies. Additional information is available at the Company's websites - admtronics.com and concepttoquantity.com.
Except for historical information contained herein, the matters set forth in this news release are "forward looking" statements (as defined in the Private Securities Litigation Reform Act of 1995). Although ADMT believes the expectations reflected in such forward looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT's filings with the SEC, news releases and other communications.
SOURCE ADM Tronics Unlimited, Inc.
Copyright 2014 PR Newswire
